Furthermore, our results also suggest that long term changes in secretion of gut hormone PYY and adiponectin, in synergy with other hormones that may include GLP1 and CRP, may contribute to improvements in insulin resistance and therefore reduction in future cardiovascular risk following bariatric surgery. Here, GCG is linked to Insulin resistance.